Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten.
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.
India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December. The regulator has also declined to accept the company’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.
Pfizer says its application is supported by data from a global study that shows an overall efficacy rate of 95 per cent with no vaccine-related, serious safety concerns. It also says that, based on the same data, the vaccine developed with German partner BioNTech has been approved in Britain, the United States, the European Union and Canada.
“The data collected has been endorsed by various regulatory agencies (including the most evolved) and they have given EUA [based on] … that data,” the firm said in an emailed response to questions, including on India’s demand for a local trial.
“Given our exclusive priority to government supply, we look forward to a confirmation from the government on necessary supplies, [on the] basis [of] which we will take the regulatory process forward, as we have done across the world,” it added.
Last week, government officials in some EU countries said Pfizer had slashed in half deliveries to them, causing frustration and hampering vaccination drives.
Officials have had discussions with both Pfizer and its US rival Moderna Inc about making their shots in India, given its large pharmaceutical capacity.
- Molbio’s Nipah test kit gets DCGI approval - September 9, 2021
- 61 test negative for Nipah so far: Kerala Health Minister Veena George - September 9, 2021
- RT-PCR accounted for over 70 percent tests conducted in Delhi in last five months - September 9, 2021
- Punjab govt to open 300 new Opioid Assisted Treatment centres to tackle drug addiction - September 9, 2021
- Over five crore people vaccinated in Madhya Pradesh so far - September 9, 2021
- BMC issues new Ganpati festival norms – No pandal darshan, curbs on yatra participants across Mumbai - September 8, 2021
- Early screening & risk assessment through breakthrough technologies - September 8, 2021
- 30 test negative for Nipah so far: Kerala Health Minister Veena George - September 8, 2021
- 88 oxygen generation plants functional in MP, says CM Shivraj Singh Chouhan - September 8, 2021
- Efforts grow to stamp out use of parasite drug for COVID-19 - September 8, 2021